AI Model for Classifying Breast Cancer From Histopathology Images

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

February 11, 2025

Study Completion Date

February 11, 2025

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Biopsy, Mastectomy, Histopathology

"Biopsy:~This intervention involves the collection of breast tissue samples through a biopsy procedure. These samples are obtained from women undergoing investigation for unusual cell growth and are analyzed to detect potential abnormalities, including benign, in situ, or invasive cancerous changes.~Mastectomy:~This intervention refers to the surgical removal of breast tissue, typically performed to treat or prevent the spread of breast cancer. It may involve the removal of part or all of the breast and is considered in cases of invasive breast cancer or high-risk noninvasive breast cancer.~Histopathology:~This intervention focuses on the microscopic examination of breast tissue samples collected through biopsy or mastectomy. Histopathological analysis is conducted to assess cellular abnormalities, determine the presence of cancer, and classify the tissue as benign, in situ, or invasive, providing the basis for diagnosis and treatment decisions."

Trial Locations (1)

1212

RECRUITING

National Institute of Cancer Research & Hospital (NICRH), Dhaka

All Listed Sponsors
collaborator

National Institute of Cancer Research & Hospital, Bangladesh

UNKNOWN

lead

Taufiq Hasan, PhD

OTHER